Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page
- Check3 days agoChange DetectedMassachusetts is now listed under Locations with Revision: v3.3.3, and the previous Massachusetts Locations entry and the HHS Vulnerability Disclosure link have been removed.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPublications section now states that publications are automatically filled in from PubMed, and a Revision: v3.3.2 note appears. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe notice about lapse in government funding and operating status has been removed from the page.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page shows minor layout and formatting updates to the Study Details section; no core study content or critical fields appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded a government funding notice and an updated version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference4%

- Check89 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. This indicates an updated release, but no other substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.